SARS-CoV-2 manipulates the SR-B1-mediated HDL uptake pathway for its entry
Congwen Wei(Academy of Military Medical Sciences), Hui Zhong(Kunming University of Science and Technology), Qi Gao(South China Agricultural University), Xiaopan Yang, Yulong Zong(Qingdao University), Huan Yang(Academy of Military Medical Sciences), Peng Du(Academy of Military Medical Sciences), Wanchuan Zhang(Liaoning Cancer Hospital & Institute), Luming Wan, Yumeng Peng(Academy of Military Medical Sciences), Fan Chen(82th Hospital of Pla), Rong Wang(Kunming Medical University), Wei Chen(Southeast University), Jianmin Li(Model Animal Research Center), Yufei Wang(First Affiliated Hospital of Zhengzhou University), Yanhong Zhang(Academy of Military Medical Sciences), Jun Zhang(Hebei Agricultural University), Zhe Zhang(Zhengzhou University), Xuejun Wang(Wuhan University), Xiaoli Yang(Guilin Medical University), Feng Yin(Taian City Central Hospital), Jing Gong(174th hospital of the People's Liberation Army), Huilong Li(Fujian Medical University), Xiaolin Wang(Ministry of Agriculture and Rural Affairs), Qiulin Yan(Shenyang Pharmaceutical University), Haotian Lin(Zhejiang University), Yuan Cao(82th Hospital of Pla), Rui Zhang(Shanghai University of Engineering Science), Jin Sun(Academy of Military Medical Sciences)
Cited by 5
Related Papers
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry
|Nature Metabolism|2020|304
The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein
|The Journal of Immunology|2010|235
Antibody Responses to SARS-CoV-2 in Patients of Novel Coronavirus Disease 2019
|SSRN Electronic Journal|2020|222
DNA methylation in nasal epithelium, atopy, and atopic asthma in children: a genome-wide study
|The Lancet Respiratory Medicine|2018|208